HR 5027 United States House · 118th Congress

Chronic Kidney Disease Improvement in Research and Treatment Act of 2023

This bill expands Medicare benefits for chronic kidney disease patients by adding kidney disease screening to annual wellness visits and broadening education options to include more healthcare professionals like nurse practitioners. It updates payment systems to better cover innovative kidney treatments, including new drugs and devices, and requires a study on increasing kidney transplant rates. The bill also aims to improve the kidney care workforce by expanding training opportunities in underserved areas and ensures Medicare Advantage plans properly cover new kidney therapies. These changes directly affect Medicare beneficiaries with kidney disease, dialysis centers, and nephrology providers, with key provisions taking effect in 2022-2024.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Jul 2023

Committee Review

Floor Vote

President

Introduced Jul 27, 2023 Last action Dec 17, 2024

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Dec 17, 2024

Committee

Referred to the Subcommittee on Health.

lower

Jul 28, 2023

Committee

Referred to the Subcommittee on Health.

lower

Jul 27, 2023

Committee

Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Jul 27, 2023

Introduced

Introduced in House

lower

1 primary · 13 co-sponsors